Updated: April 9, 2026
Mycophenolate Mofetil Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
- How Mycophenolate Mofetil Is Metabolized (Why Interactions Matter)
- Interactions That Reduce Mycophenolate Mofetil Levels (Reducing Effectiveness)
- Interactions That Increase Mycophenolate Mofetil Levels or Side Effects
- Absolute Avoid: Do Not Combine with Azathioprine
- Vaccines and Mycophenolate Mofetil
- Food Interactions
- What to Tell Your Doctor and Pharmacist
Mycophenolate mofetil (CellCept) has important drug interactions that can reduce its effectiveness or increase side effects. Here's what to know and what to tell your doctor.
Mycophenolate mofetil (CellCept) is a sensitive drug when it comes to interactions. Because it is metabolized in a specific way and its blood levels are critical for its effectiveness, other drugs can easily increase or decrease how much mycophenolic acid is actually reaching your immune cells. Some interactions reduce the drug's effectiveness — potentially exposing transplant recipients to rejection risk. Others increase the drug's levels or side effects.
This guide covers the most important drug interactions with mycophenolate mofetil — and gives you clear guidance on what to tell your prescriber and pharmacist.
How Mycophenolate Mofetil Is Metabolized (Why Interactions Matter)
Mycophenolate mofetil is converted to mycophenolic acid (MPA) in the gut and blood. MPA undergoes glucuronidation in the liver to form an inactive metabolite (MPAG), which is excreted in bile and then undergoes enterohepatic recirculation — it is reabsorbed in the intestine, reconverted to MPA, and reaches a secondary peak in blood levels. Anything that interferes with this absorption, glucuronidation, or enterohepatic cycle can affect MMF blood levels significantly.
Interactions That Reduce Mycophenolate Mofetil Levels (Reducing Effectiveness)
- Cyclosporine (Sandimmune, Neoral): Cyclosporine inhibits the enterohepatic recirculation of MPA — reducing MMF blood levels by up to 30-50% compared to tacrolimus-based regimens. Patients on cyclosporine + MMF may need higher MMF doses; monitor and discuss with your transplant team.
- Antacids (aluminum/magnesium hydroxide): Antacids reduce the absorption of mycophenolate mofetil by neutralizing stomach acid, which is needed for proper dissolution. Avoid taking antacids within 2 hours of your MMF dose.
- Proton pump inhibitors (PPIs) — esomeprazole (Nexium), dexlansoprazole, omeprazole, pantoprazole: PPIs raise gastric pH, which can reduce the absorption of mycophenolate mofetil from the gut. The clinical significance varies, but if you're on a PPI long-term, your provider should be aware.
- H2 blockers (famotidine, ranitidine): Similar mechanism to PPIs — raise gastric pH and may reduce MMF absorption. Discuss with your provider if you need acid suppression.
- Bile acid sequestrants (cholestyramine, colesevelam): These drugs bind to bile acids in the gut, which interferes with the enterohepatic recirculation of MPA — potentially reducing MMF levels by 40% or more. Avoid concurrent use. If clinically necessary, they should be separated by several hours and levels monitored.
- Rifamycins (rifampin, rifabutin): Rifampin significantly reduces MPA exposure by inducing enzymes that speed up MPAG glucuronidation and increasing biliary excretion. This is a clinically significant interaction that may require MMF dose adjustment.
- Metronidazole + norfloxacin (or other antibiotics affecting gut flora): Some antibiotics reduce intestinal bacteria responsible for reconverting the inactive metabolite back to MPA, potentially reducing MMF blood levels.
Interactions That Increase Mycophenolate Mofetil Levels or Side Effects
- NSAIDs (ibuprofen, naproxen, diclofenac, indomethacin): NSAIDs compete with MPA for renal tubular secretion, increasing MPA blood levels. This can amplify both the immunosuppressive effects and the side effect risk of MMF. Avoid NSAIDs if possible; use acetaminophen for pain relief instead.
- Acyclovir, ganciclovir, valacyclovir, valganciclovir: These antiviral drugs (commonly used to prevent CMV infection in transplant patients) compete with the MPAG metabolite for renal tubular secretion. This can increase the levels of both MMF metabolites and the antiviral drug. Monitor carefully — this combination is common in transplant care but requires attention.
- Other immunosuppressants (tacrolimus, cyclosporine, sirolimus, corticosteroids): Combining multiple immunosuppressants increases overall immunosuppression and the risk of infections and malignancies. These combinations are intentional in transplant regimens but require careful balancing and monitoring.
Absolute Avoid: Do Not Combine with Azathioprine
Mycophenolate mofetil and azathioprine (Imuran) should never be used together. They are therapeutic duplicates — both purine antimetabolites — and concurrent use dramatically increases the risk of severe bone marrow suppression, leukopenia, and life-threatening infections. If your prescriber is considering switching between these two medications, they should be substituted, never combined.
Vaccines and Mycophenolate Mofetil
Live vaccines must be avoided while on mycophenolate mofetil. This includes vaccines for measles-mumps-rubella (MMR), varicella (chickenpox), yellow fever, live influenza (nasal spray), live shingles (Zostavax — the older injectable shingles vaccine), and others. Getting a live vaccine while immunosuppressed can cause serious vaccine-strain infections.
Inactivated vaccines (flu shot, Shingrix recombinant shingles vaccine, pneumococcal vaccines, COVID-19 mRNA vaccines) are safe but may produce a weaker immune response. Still, you should stay up to date on these — they provide partial protection even in immunosuppressed patients.
Food Interactions
Food generally reduces and delays the absorption of mycophenolate mofetil, which is why it's directed to be taken on an empty stomach. However, food does not eliminate absorption — if GI side effects are severe, taking MMF with a small amount of food may reduce nausea and diarrhea. Discuss this tradeoff with your provider. Grape and pomegranate juice should be avoided as they may affect drug metabolism.
What to Tell Your Doctor and Pharmacist
Any time you're starting a new medication — prescription or over-the-counter — tell your prescriber and pharmacist that you take mycophenolate mofetil. This is especially important for:
- Any antibiotic or antifungal
- Any pain reliever (avoid NSAIDs; use acetaminophen instead)
- Any heartburn or acid reflux medication (especially PPIs)
- Any cholesterol or bile acid-lowering drug
- Any herbal supplement or vitamin (some can affect drug metabolism)
- Any vaccine — to confirm it is an inactivated (not live) formulation
For more detail on side effects of mycophenolate mofetil, see: Mycophenolate Mofetil Side Effects: What to Expect and When to Call Your Doctor. And if you need help finding your prescription in stock: How to Find Mycophenolate Mofetil in Stock Near You.
Frequently Asked Questions
Ibuprofen and other NSAIDs (naproxen, diclofenac, indomethacin) are not recommended with mycophenolate mofetil. NSAIDs compete for renal excretion with mycophenolate metabolites, potentially increasing drug levels and side effects. For pain relief, acetaminophen (Tylenol) is generally the preferred option for patients on mycophenolate. Ask your provider before taking any OTC pain reliever.
Yes. Both antacids (aluminum/magnesium hydroxide) and proton pump inhibitors (PPIs like esomeprazole, omeprazole) can reduce the absorption of mycophenolate mofetil by raising stomach pH. Avoid taking antacids within 2 hours of your MMF dose. If you need long-term acid suppression, discuss the timing and clinical impact with your prescriber.
No. Azathioprine and mycophenolate mofetil are both purine antimetabolites and must never be taken together. Combining them causes severe additive immunosuppression and dramatically increases the risk of bone marrow suppression, dangerous leukopenia, and life-threatening infections. If you are switching between these medications, they must be substituted — not combined.
Cyclosporine inhibits the enterohepatic recirculation of mycophenolic acid — the process by which the active drug is reabsorbed in the intestine after liver processing. This can reduce mycophenolate blood levels by 30-50% compared to patients on tacrolimus. Patients on cyclosporine-based regimens may need higher MMF doses to achieve equivalent immunosuppression. Your transplant team monitors this.
Inactivated vaccines (flu shot, pneumococcal, COVID-19 mRNA, Shingrix recombinant shingles vaccine) are safe to receive, though response may be reduced in immunosuppressed patients. Live vaccines (MMR, varicella, live shingles vaccine Zostavax, live intranasal flu) must be avoided while on mycophenolate mofetil. Talk to your provider before any vaccination.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Mycophenolate Mofetil also looked for:
More about Mycophenolate Mofetil
32,827 have already found their meds with Medfinder.
Start your search today.





